Oxford Biomedica Plc (OXBDF)
11.19
0.00 (0.00%)
USD |
OTCM |
Feb 06, 16:00
Price Chart
Key Stats
| Price and Performance | |
|---|---|
| Market Cap | 1.345B |
| 52 Week High (Daily) | |
| 52 Week Low (Daily) | |
| All-Time High (Daily) | |
| Year to Date Total Returns (Daily) | |
| 1 Month Total Returns (Daily) | |
| 1 Year Total Returns (Daily) | 121.8% |
| Valuation | |
| PE Ratio | -- |
| PE Ratio (Forward) | |
| PS Ratio | 6.064 |
| Price to Book Value | -- |
| EV to EBITDA | |
| Dividend | |
|---|---|
| Dividend | -- |
| Dividend Yield (Forward) | |
| Financials | |
| Revenue (5 Year Growth) | |
| Revenue (Quarterly YoY Growth) | |
| EPS Diluted (5 Year Growth) | |
| EPS Diluted (Quarterly YoY Growth) | |
| Debt to Equity Ratio | -- |
| Return on Equity | |
| Return on Assets | |
| Risk | |
| Beta (5Y) | |
| Max Drawdown (5Y) | 90.85% |
Profile
| Oxford Biomedica Plc is a biopharmaceutical company, which engages in the research and development of gene and cell therapy. The firm also provides bioprocessing and process development services to third parties. The company was founded by Alan J. Kingsman and Susan M. Kingsman in 1995 and is headquartered in Oxford, the United Kingdom. |
| URL | http://www.oxfordbiomedica.co.uk |
| Investor Relations URL | N/A |
| HQ State/Province | Oxfordshire |
| Sector | Health Care |
| Industry | Biotechnology |
| Next Earnings Release | Apr. 09, 2026 (est.) |
| Last Earnings Release | Sep. 23, 2025 |
| Next Ex-Dividend Date | N/A |
| Last Ex-Dividend Date | N/A |
Profile
| Oxford Biomedica Plc is a biopharmaceutical company, which engages in the research and development of gene and cell therapy. The firm also provides bioprocessing and process development services to third parties. The company was founded by Alan J. Kingsman and Susan M. Kingsman in 1995 and is headquartered in Oxford, the United Kingdom. |
| URL | http://www.oxfordbiomedica.co.uk |
| Investor Relations URL | N/A |
| HQ State/Province | Oxfordshire |
| Sector | Health Care |
| Industry | Biotechnology |
| Next Earnings Release | Apr. 09, 2026 (est.) |
| Last Earnings Release | Sep. 23, 2025 |
| Next Ex-Dividend Date | N/A |
| Last Ex-Dividend Date | N/A |